Although the US Food and Drug Administration (FDA) announced Wednesday that it will not recommend Pfizer-BioNTech’s third COVID-19 vaccination for most Americans younger than 65, Mississippi resident Jen Buckley, 50, said she and her husband decided to keep getting the booster vaccine.
“We got the second vaccination almost eight months ago,” he said, explaining their reasons for getting the third vaccination. “And I’m afraid the effects of the second vaccine may have weakened. We don’t want to leave ourselves vulnerable.”
In addition to senior citizens, the FDA allows booster vaccinations for those aged 18 to 64 who are at high risk of severe COVID-19 or who work in places where there is a high risk of contracting it.
Buckley and her husband fear they don’t meet the criteria, even though she takes medications that weaken her immune system and her husband suffers from high blood pressure and asthma.
Buckley’s worries are made worse because he lives in Jackson County, Mississippi, where only 37 percent of the population has been vaccinated with the full dose.
Dr Anthony Fauci, President Joe Biden’s chief medical adviser, said he would support a third dose for all Americans, if future data showed the vaccine worked.
Sufficient data are not yet available in America, but research from Israel shows that while the efficacy of the coronavirus vaccine diminishes over time and a third shot of the Pfizer-BioNTech vaccine is rated to protect against COVID-19 transmission by up to 95 percent. (ps/ka)